Global Mupirocin Ointment Market By Application (Impetigo (School Sores), Folliculitis, Furunculosis (Boils), Ecthyma, Infected Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and Ichthyosis), Infected Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds), Prevent Development of Infection and Promote Healing in Minor Burns, Biopsy Sites, Minor Cuts and Other Clean Lesions); By Packaging Size (1 gm, 15 gm, 22 gm, Others); By Age Group (Pediatric, Adult and Elderly); By Distribution Channel (Online, Offline); By End Use (Hospitals, Clinics, Home Care, Others); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Global mupirocin ointment market was valued at US$ 316.89 Mn in 2021, growing at an estimated CAGR of 3% over the forecast period. Mupirocin ointment happens to be a topical cream that is used in order to provide treatment to secondarily infected traumatic skin lesions that have been caused due to a certain bacterium. This ointment is mainly used to provide a cure to disease like impetigo as it kills the bacteria or puts an end to its growth. This highly prescribed ointment is witnessing a massive demand and this is the reason behind the growth of the global mupirocin ointment market,
The progress of the global mupirocin ointment market was hugely hampered during the period of the coronavirus pandemic. Unavailability of medical services during the period of adversity caused a slump in the demand for the mupirocin.
By Application
On the basis of the application, the global mupirocin ointment market has been bifurcated into Impetigo (School Sores), Folliculitis, Furunculosis (Boils), Ecthyma, Infected Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and Ichthyosis), Infected Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds), and Prevent Development of Infection and Promote Healing in Minor Burns, Biopsy Sites, Minor Cuts and Other Clean Lesions. As stated above mupirocin ointment is majorly used to treat impetigo (school sores), and this is the reason the segment accounts for majority of revenue generated by this market.
By Packaging Size
On the basis of packaging size, the global mupirocin ointment market has been divided into 1 gm, 15 gm, 22 gm and others. The 15 gm segment mints most of the money for this market. This is because this size of packaging is prescribed the most by the physicians.
By Age Group
The age group segment of the global mupirocin ointment market has been segmented into paediatric, and adult and elderly. The chances of infants and children getting infected with specific bacteria is extremely high and this is the reason why the paediatric segment accumulates most of the money for the market. On the other hand, there has been surge in cases of bacterial infection in adults and elderly people, hence this segment will mint money at the fastest rate.
Global Mupirocin Ointment Market Revenue & Forecast, (US$ Million), 2022 – 2030
By Distribution Channel
The distribution channel segment of the global mupirocin ointment market has been segmented into online, and offline. As the mupirocin ointment is sold only after a prescription from practicing doctor or medical physician, hence buying from a chemist store is extremely convenient. This is the reason why the offline segment accounts for most of money made by this market.
By End Use
The end use segment of the global mupirocin ointment market has been segmented into hospitals, clinics, home care and others. The hospitals segment has an edge over other segments and this is why it mints more money for the market. The number of people getting themselves or their beloved ones treated at the hospitals is the highest compared to other segments.
Region Outlook
On the basis of region, the global mupirocin ointment market has been divided into Latin America, Europe, North America, Asia-Pacific and others. The region of North America has been accounting for most of the money for this market. Leading pharmaceutical companies in the countries like the United States and Canada along with higher prevalence of bacterial infection in the adults is what is driving the growth of this market.
Competitive Landscape
The report provides both, qualitative and quantitative research of global mupirocin ointment market as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the major players operating in the global mupirocin ointment market are listed below:
- Cipla Limited
- Glaxosmithkline
- Glenmark Pharmaceutical Inc.
- Perrigo Company
- Sandoz AG
- Sun Pharma
- Teva Pharmaceuticals USA, Inc.
- Texas
- Unichem Laboratories
- Other Market Participants
Global Mupirocin Ointment Market
By Application
- Impetigo (School Sores)
- Folliculitis
- Furunculosis (Boils)
- Ecthyma
- Infected Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and Ichthyosis)
- Infected Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
- Prevent Development of Infection and Promote Healing in Minor Burns, Biopsy Sites, Minor Cuts and Other Clean Lesions
By Teaching Format
- 1 gm
- 15 gm
- 22 gm
- Others
By Age Group
- Paediatric
- Adult and Elderly
By Distribution Channel
- Online
- Offline
By End Use
- Hospitals
- Clinics
- Home Care
- Others
By Region
- North America
- U.S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2020
1.2.2. Base
Year: 2021
1.2.3. Forecast
Years: 2022 – 2030
2.
Key Target Audiences
3.
Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4.
Recommendations and
Insights from AMI’s Perspective**
5.
Holistic Overview of
Mupirocin Ointment Market
6.
Market Synopsis: Mupirocin Ointment Market
7.
Mupirocin Ointment Market
Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Mupirocin Ointment Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Mupirocin Ointment Market
7.6. Porter’s Five
Force Analysis
8.
Global Mupirocin Ointment
Market Analysis and Forecasts, 2022 – 2030
8.1. Overview
8.1.1. Global
Mupirocin Ointment Market Revenue (US$ Mn)
8.2. Global
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
8.2.1. Impetigo
(School Sores)
8.2.1.1. Definition
8.2.1.2. Market
Estimation and Penetration, 2015 - 2021
8.2.1.3. Market
Forecast, 2022 – 2030
8.2.1.4. Compound
Annual Growth Rate (CAGR)
8.2.1.5. Regional
Bifurcation
8.2.1.5.1. North
America
8.2.1.5.1.1. Market
Estimation, 2015 - 2021
8.2.1.5.1.2. Market
Forecast, 2022 – 2030
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 - 2021
8.2.1.5.2.2. Market
Forecast, 2022 – 2030
8.2.1.5.3. Asia
Pacific
8.2.1.5.3.1. Market
Estimation, 2015 - 2021
8.2.1.5.3.2. Market
Forecast, 2022 – 2030
8.2.1.5.4. Middle
East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 - 2021
8.2.1.5.4.2. Market
Forecast, 2022 – 2030
8.2.1.5.5. Latin
America
8.2.1.5.5.1. Market
Estimation, 2015 - 2021
8.2.1.5.5.2. Market
Forecast, 2022 – 2030
8.2.2. Folliculitis
8.2.2.1. Definition
8.2.2.2. Market
Estimation and Penetration, 2015 - 2021
8.2.2.3. Market
Forecast, 2022 – 2030
8.2.2.4. Compound
Annual Growth Rate (CAGR)
8.2.2.5. Regional
Bifurcation
8.2.2.5.1. North
America
8.2.2.5.1.1. Market
Estimation, 2015 - 2021
8.2.2.5.1.2. Market
Forecast, 2022 – 2030
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2021
8.2.2.5.2.2. Market
Forecast, 2022 – 2030
8.2.2.5.3. Asia
Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2021
8.2.2.5.3.2. Market
Forecast, 2022 – 2030
8.2.2.5.4. Middle
East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2021
8.2.2.5.4.2. Market
Forecast, 2022 – 2030
8.2.2.5.5. Latin
America
8.2.2.5.5.1. Market
Estimation, 2015 - 2021
8.2.2.5.5.2. Market
Forecast, 2022 – 2030
8.2.3. Furunculosis
(Boils)
8.2.3.1. Definition
8.2.3.2. Market
Estimation and Penetration, 2015 - 2021
8.2.3.3. Market
Forecast, 2022 – 2030
8.2.3.4. Compound
Annual Growth Rate (CAGR)
8.2.3.5. Regional
Bifurcation
8.2.3.5.1. North
America
8.2.3.5.1.1. Market
Estimation, 2015 - 2021
8.2.3.5.1.2. Market
Forecast, 2022 – 2030
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 - 2021
8.2.3.5.2.2. Market
Forecast, 2022 – 2030
8.2.3.5.3. Asia
Pacific
8.2.3.5.3.1. Market
Estimation, 2015 - 2021
8.2.3.5.3.2. Market
Forecast, 2022 – 2030
8.2.3.5.4. Middle
East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 - 2021
8.2.3.5.4.2. Market
Forecast, 2022 – 2030
8.2.3.5.5. Latin
America
8.2.3.5.5.1. Market
Estimation, 2015 - 2021
8.2.3.5.5.2. Market
Forecast, 2022 – 2030
8.2.4. Ecthyma
8.2.4.1. Definition
8.2.4.2. Market
Estimation and Penetration, 2015 - 2021
8.2.4.3. Market
Forecast, 2022 – 2030
8.2.4.4. Compound
Annual Growth Rate (CAGR)
8.2.4.5. Regional
Bifurcation
8.2.4.5.1. North
America
8.2.4.5.1.1. Market
Estimation, 2015 - 2021
8.2.4.5.1.2. Market
Forecast, 2022 – 2030
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2015 - 2021
8.2.4.5.2.2. Market
Forecast, 2022 – 2030
8.2.4.5.3. Asia
Pacific
8.2.4.5.3.1. Market
Estimation, 2015 - 2021
8.2.4.5.3.2. Market
Forecast, 2022 – 2030
8.2.4.5.4. Middle
East and Africa
8.2.4.5.4.1. Market
Estimation, 2015 - 2021
8.2.4.5.4.2. Market
Forecast, 2022 – 2030
8.2.4.5.5. Latin
America
8.2.4.5.5.1. Market
Estimation, 2015 - 2021
8.2.4.5.5.2. Market
Forecast, 2022 – 2030
8.2.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
8.2.5.1. Definition
8.2.5.2. Market
Estimation and Penetration, 2015 - 2021
8.2.5.3. Market
Forecast, 2022 – 2030
8.2.5.4. Compound
Annual Growth Rate (CAGR)
8.2.5.5. Regional
Bifurcation
8.2.5.5.1. North
America
8.2.5.5.1.1. Market
Estimation, 2015 - 2021
8.2.5.5.1.2. Market
Forecast, 2022 – 2030
8.2.5.5.2. Europe
8.2.5.5.2.1. Market
Estimation, 2015 - 2021
8.2.5.5.2.2. Market
Forecast, 2022 – 2030
8.2.5.5.3. Asia
Pacific
8.2.5.5.3.1. Market
Estimation, 2015 - 2021
8.2.5.5.3.2. Market
Forecast, 2022 – 2030
8.2.5.5.4. Middle
East and Africa
8.2.5.5.4.1. Market
Estimation, 2015 - 2021
8.2.5.5.4.2. Market
Forecast, 2022 – 2030
8.2.5.5.5. Latin
America
8.2.5.5.5.1. Market
Estimation, 2015 - 2021
8.2.5.5.5.2. Market
Forecast, 2022 – 2030
8.2.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
8.2.6.1. Definition
8.2.6.2. Market
Estimation and Penetration, 2015 - 2021
8.2.6.3. Market
Forecast, 2022 – 2030
8.2.6.4. Compound
Annual Growth Rate (CAGR)
8.2.6.5. Regional
Bifurcation
8.2.6.5.1. North
America
8.2.6.5.1.1. Market
Estimation, 2015 - 2021
8.2.6.5.1.2. Market
Forecast, 2022 – 2030
8.2.6.5.2. Europe
8.2.6.5.2.1. Market
Estimation, 2015 - 2021
8.2.6.5.2.2. Market
Forecast, 2022 – 2030
8.2.6.5.3. Asia
Pacific
8.2.6.5.3.1. Market
Estimation, 2015 - 2021
8.2.6.5.3.2. Market
Forecast, 2022 – 2030
8.2.6.5.4. Middle
East and Africa
8.2.6.5.4.1. Market
Estimation, 2015 - 2021
8.2.6.5.4.2. Market
Forecast, 2022 – 2030
8.2.6.5.5. Latin
America
8.2.6.5.5.1. Market
Estimation, 2015 - 2021
8.2.6.5.5.2. Market
Forecast, 2022 – 2030
8.2.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
8.2.7.1. Definition
8.2.7.2. Market
Estimation and Penetration, 2015 - 2021
8.2.7.3. Market
Forecast, 2022 – 2030
8.2.7.4. Compound
Annual Growth Rate (CAGR)
8.2.7.5. Regional
Bifurcation
8.2.7.5.1. North
America
8.2.7.5.1.1. Market
Estimation, 2015 - 2021
8.2.7.5.1.2. Market
Forecast, 2022 – 2030
8.2.7.5.2. Europe
8.2.7.5.2.1. Market
Estimation, 2015 - 2021
8.2.7.5.2.2. Market
Forecast, 2022 – 2030
8.2.7.5.3. Asia
Pacific
8.2.7.5.3.1. Market
Estimation, 2015 - 2021
8.2.7.5.3.2. Market
Forecast, 2022 – 2030
8.2.7.5.4. Middle
East and Africa
8.2.7.5.4.1. Market
Estimation, 2015 - 2021
8.2.7.5.4.2. Market
Forecast, 2022 – 2030
8.2.7.5.5. Latin
America
8.2.7.5.5.1. Market
Estimation, 2015 - 2021
8.2.7.5.5.2. Market
Forecast, 2022 – 2030
8.3. Key
Segment for Channeling Investments
8.3.1. By
Application
9.
Global Mupirocin Ointment
Market Analysis and Forecasts, 2022 – 2030
9.1. Overview
9.2. Global
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging Size
9.2.1. 1 gm
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 - 2021
9.2.1.3. Market
Forecast, 2022 – 2030
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2015 - 2021
9.2.1.5.1.2. Market
Forecast, 2022 – 2030
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2021
9.2.1.5.2.2. Market
Forecast, 2022 – 2030
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2021
9.2.1.5.3.2. Market
Forecast, 2022 – 2030
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2021
9.2.1.5.4.2. Market
Forecast, 2022 – 2030
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2015 - 2021
9.2.1.5.5.2. Market
Forecast, 2022 – 2030
9.2.2. 15 gm
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2015 - 2021
9.2.2.3. Market
Forecast, 2022 – 2030
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market
Estimation, 2015 - 2021
9.2.2.5.1.2. Market
Forecast, 2022 – 2030
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2021
9.2.2.5.2.2. Market
Forecast, 2022 – 2030
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2021
9.2.2.5.3.2. Market
Forecast, 2022 – 2030
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2021
9.2.2.5.4.2. Market
Forecast, 2022 – 2030
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market
Estimation, 2015 - 2021
9.2.2.5.5.2. Market
Forecast, 2022 – 2030
9.2.3. 22 gm
9.2.3.1. Definition
9.2.3.2. Market
Estimation and Penetration, 2015 - 2021
9.2.3.3. Market
Forecast, 2022 – 2030
9.2.3.4. Compound
Annual Growth Rate (CAGR)
9.2.3.5. Regional
Bifurcation
9.2.3.5.1. North
America
9.2.3.5.1.1. Market
Estimation, 2015 - 2021
9.2.3.5.1.2. Market
Forecast, 2022 – 2030
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2021
9.2.3.5.2.2. Market
Forecast, 2022 – 2030
9.2.3.5.3. Asia
Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2021
9.2.3.5.3.2. Market
Forecast, 2022 – 2030
9.2.3.5.4. Middle
East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2021
9.2.3.5.4.2. Market
Forecast, 2022 – 2030
9.2.3.5.5. Latin
America
9.2.3.5.5.1. Market
Estimation, 2015 - 2021
9.2.3.5.5.2. Market
Forecast, 2022 – 2030
9.2.4. Others
9.2.4.1. Definition
9.2.4.2. Market
Estimation and Penetration, 2015 - 2021
9.2.4.3. Market
Forecast, 2022 – 2030
9.2.4.4. Compound
Annual Growth Rate (CAGR)
9.2.4.5. Regional
Bifurcation
9.2.4.5.1. North
America
9.2.4.5.1.1. Market
Estimation, 2015 - 2021
9.2.4.5.1.2. Market
Forecast, 2022 – 2030
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 - 2021
9.2.4.5.2.2. Market
Forecast, 2022 – 2030
9.2.4.5.3. Asia
Pacific
9.2.4.5.3.1. Market
Estimation, 2015 - 2021
9.2.4.5.3.2. Market
Forecast, 2022 – 2030
9.2.4.5.4. Middle
East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 - 2021
9.2.4.5.4.2. Market
Forecast, 2022 – 2030
9.2.4.5.5. Latin
America
9.2.4.5.5.1. Market
Estimation, 2015 - 2021
9.2.4.5.5.2. Market
Forecast, 2022 – 2030
9.3. Key
Segment for Channeling Investments
9.3.1. By
Packaging Size
10.
Global Mupirocin Ointment
Market Analysis and Forecasts, 2022 – 2030
10.1. Overview
10.2. Global
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
10.2.1. Paediatric
10.2.1.1. Definition
10.2.1.2. Market
Estimation and Penetration, 2015 - 2021
10.2.1.3. Market
Forecast, 2022 – 2030
10.2.1.4. Compound
Annual Growth Rate (CAGR)
10.2.1.5. Regional
Bifurcation
10.2.1.5.1. North
America
10.2.1.5.1.1. Market
Estimation, 2015 - 2021
10.2.1.5.1.2. Market
Forecast, 2022 – 2030
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2021
10.2.1.5.2.2. Market
Forecast, 2022 – 2030
10.2.1.5.3. Asia
Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2021
10.2.1.5.3.2. Market
Forecast, 2022 – 2030
10.2.1.5.4. Middle
East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2021
10.2.1.5.4.2. Market
Forecast, 2022 – 2030
10.2.1.5.5. Latin
America
10.2.1.5.5.1. Market
Estimation, 2015 - 2021
10.2.1.5.5.2. Market
Forecast, 2022 – 2030
10.2.2. Adult
and Elderly
10.2.2.1. Definition
10.2.2.2. Market
Estimation and Penetration, 2015 - 2021
10.2.2.3. Market
Forecast, 2022 – 2030
10.2.2.4. Compound
Annual Growth Rate (CAGR)
10.2.2.5. Regional
Bifurcation
10.2.2.5.1. North
America
10.2.2.5.1.1. Market
Estimation, 2015 - 2021
10.2.2.5.1.2. Market
Forecast, 2022 – 2030
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2021
10.2.2.5.2.2. Market
Forecast, 2022 – 2030
10.2.2.5.3. Asia
Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2021
10.2.2.5.3.2. Market
Forecast, 2022 – 2030
10.2.2.5.4. Middle
East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2021
10.2.2.5.4.2. Market
Forecast, 2022 – 2030
10.2.2.5.5. Latin
America
10.2.2.5.5.1. Market
Estimation, 2015 - 2021
10.2.2.5.5.2. Market
Forecast, 2022 – 2030
10.3. Key
Segment for Channeling Investments
10.3.1. By Age
Group
11.
Global Mupirocin Ointment
Market Analysis and Forecasts, 2022 – 2030
11.1. Overview
11.2. Global
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
11.2.1. Online
11.2.1.1. Definition
11.2.1.2. Market
Estimation and Penetration, 2015 - 2021
11.2.1.3. Market
Forecast, 2022 – 2030
11.2.1.4. Compound
Annual Growth Rate (CAGR)
11.2.1.5. Regional
Bifurcation
11.2.1.5.1. North
America
11.2.1.5.1.1. Market
Estimation, 2015 - 2021
11.2.1.5.1.2. Market
Forecast, 2022 – 2030
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2021
11.2.1.5.2.2. Market
Forecast, 2022 – 2030
11.2.1.5.3. Asia
Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2021
11.2.1.5.3.2. Market
Forecast, 2022 – 2030
11.2.1.5.4. Middle
East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2021
11.2.1.5.4.2. Market
Forecast, 2022 – 2030
11.2.1.5.5. Latin
America
11.2.1.5.5.1. Market
Estimation, 2015 - 2021
11.2.1.5.5.2. Market
Forecast, 2022 – 2030
11.2.2. Offline
11.2.2.1. Definition
11.2.2.2. Market
Estimation and Penetration, 2015 - 2021
11.2.2.3. Market
Forecast, 2022 – 2030
11.2.2.4. Compound
Annual Growth Rate (CAGR)
11.2.2.5. Regional
Bifurcation
11.2.2.5.1. North
America
11.2.2.5.1.1. Market
Estimation, 2015 - 2021
11.2.2.5.1.2. Market
Forecast, 2022 – 2030
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2021
11.2.2.5.2.2. Market
Forecast, 2022 – 2030
11.2.2.5.3. Asia
Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2021
11.2.2.5.3.2. Market
Forecast, 2022 – 2030
11.2.2.5.4. Middle
East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2021
11.2.2.5.4.2. Market
Forecast, 2022 – 2030
11.2.2.5.5. Latin
America
11.2.2.5.5.1. Market
Estimation, 2015 - 2021
11.2.2.5.5.2. Market
Forecast, 2022 – 2030
11.3. Key
Segment for Channeling Investments
11.3.1. By
Distribution Channel
12.
Global Mupirocin Ointment
Market Analysis and Forecasts, 2022 – 2030
12.1. Overview
12.2. Global
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
12.2.1. Hospitals
12.2.1.1. Definition
12.2.1.2. Market
Estimation and Penetration, 2015 - 2021
12.2.1.3. Market
Forecast, 2022 – 2030
12.2.1.4. Compound
Annual Growth Rate (CAGR)
12.2.1.5. Regional
Bifurcation
12.2.1.5.1. North
America
12.2.1.5.1.1. Market
Estimation, 2015 - 2021
12.2.1.5.1.2. Market
Forecast, 2022 – 2030
12.2.1.5.2. Europe
12.2.1.5.2.1. Market
Estimation, 2015 - 2021
12.2.1.5.2.2. Market
Forecast, 2022 – 2030
12.2.1.5.3. Asia
Pacific
12.2.1.5.3.1. Market
Estimation, 2015 - 2021
12.2.1.5.3.2. Market
Forecast, 2022 – 2030
12.2.1.5.4. Middle
East and Africa
12.2.1.5.4.1. Market
Estimation, 2015 - 2021
12.2.1.5.4.2. Market
Forecast, 2022 – 2030
12.2.1.5.5. Latin
America
12.2.1.5.5.1. Market
Estimation, 2015 - 2021
12.2.1.5.5.2. Market
Forecast, 2022 – 2030
12.2.2. Clinics
12.2.2.1. Definition
12.2.2.2. Market
Estimation and Penetration, 2015 - 2021
12.2.2.3. Market
Forecast, 2022 – 2030
12.2.2.4. Compound
Annual Growth Rate (CAGR)
12.2.2.5. Regional
Bifurcation
12.2.2.5.1. North
America
12.2.2.5.1.1. Market
Estimation, 2015 - 2021
12.2.2.5.1.2. Market
Forecast, 2022 – 2030
12.2.2.5.2. Europe
12.2.2.5.2.1. Market
Estimation, 2015 - 2021
12.2.2.5.2.2. Market
Forecast, 2022 – 2030
12.2.2.5.3. Asia
Pacific
12.2.2.5.3.1. Market
Estimation, 2015 - 2021
12.2.2.5.3.2. Market
Forecast, 2022 – 2030
12.2.2.5.4. Middle
East and Africa
12.2.2.5.4.1. Market
Estimation, 2015 - 2021
12.2.2.5.4.2. Market
Forecast, 2022 – 2030
12.2.2.5.5. Latin
America
12.2.2.5.5.1. Market
Estimation, 2015 - 2021
12.2.2.5.5.2. Market
Forecast, 2022 – 2030
12.2.3. Home
Care
12.2.3.1. Definition
12.2.3.2. Market
Estimation and Penetration, 2015 - 2021
12.2.3.3. Market
Forecast, 2022 – 2030
12.2.3.4. Compound
Annual Growth Rate (CAGR)
12.2.3.5. Regional
Bifurcation
12.2.3.5.1. North
America
12.2.3.5.1.1. Market
Estimation, 2015 - 2021
12.2.3.5.1.2. Market
Forecast, 2022 – 2030
12.2.3.5.2. Europe
12.2.3.5.2.1. Market
Estimation, 2015 - 2021
12.2.3.5.2.2. Market
Forecast, 2022 – 2030
12.2.3.5.3. Asia
Pacific
12.2.3.5.3.1. Market
Estimation, 2015 - 2021
12.2.3.5.3.2. Market
Forecast, 2022 – 2030
12.2.3.5.4. Middle
East and Africa
12.2.3.5.4.1. Market
Estimation, 2015 - 2021
12.2.3.5.4.2. Market
Forecast, 2022 – 2030
12.2.3.5.5. Latin
America
12.2.3.5.5.1. Market
Estimation, 2015 - 2021
12.2.3.5.5.2. Market
Forecast, 2022 – 2030
12.2.4. Others
12.2.4.1. Definition
12.2.4.2. Market
Estimation and Penetration, 2015 - 2021
12.2.4.3. Market
Forecast, 2022 – 2030
12.2.4.4. Compound
Annual Growth Rate (CAGR)
12.2.4.5. Regional
Bifurcation
12.2.4.5.1. North
America
12.2.4.5.1.1. Market
Estimation, 2015 - 2021
12.2.4.5.1.2. Market
Forecast, 2022 – 2030
12.2.4.5.2. Europe
12.2.4.5.2.1. Market
Estimation, 2015 - 2021
12.2.4.5.2.2. Market
Forecast, 2022 – 2030
12.2.4.5.3. Asia
Pacific
12.2.4.5.3.1. Market
Estimation, 2015 - 2021
12.2.4.5.3.2. Market
Forecast, 2022 – 2030
12.2.4.5.4. Middle
East and Africa
12.2.4.5.4.1. Market
Estimation, 2015 - 2021
12.2.4.5.4.2. Market
Forecast, 2022 – 2030
12.2.4.5.5. Latin
America
12.2.4.5.5.1. Market
Estimation, 2015 - 2021
12.2.4.5.5.2. Market
Forecast, 2022 – 2030
12.3. Key
Segment for Channeling Investments
12.3.1. By End
Use
13.
North America Mupirocin
Ointment Market Analysis and Forecasts, 2022 – 2030
13.1. Overview
13.1.1. North
America Mupirocin Ointment Market Revenue (US$ Mn)
13.2. North
America Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Application
13.2.1. Impetigo
(School Sores)
13.2.2. Folliculitis
13.2.3. Furunculosis
(Boils)
13.2.4. Ecthyma
13.2.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
13.2.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
13.2.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
13.3. North
America Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging
Size
13.3.1. 1 gm
13.3.2. 15 gm
13.3.3. 22 gm
13.3.4. Others
13.4. North
America Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
13.4.1. Paediatric
13.4.2. Adult
and Elderly
13.5. North
America Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
13.5.1. Online
13.5.2. Offline
13.6. North
America Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
13.6.1. Hospitals
13.6.2. Clinics
13.6.3. Home
Care
13.6.4. Others
13.7. North
America Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Country
13.7.1. U.S
13.7.1.1. U.S
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
13.7.1.1.1. Impetigo
(School Sores)
13.7.1.1.2. Folliculitis
13.7.1.1.3. Furunculosis
(Boils)
13.7.1.1.4. Ecthyma
13.7.1.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
13.7.1.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
13.7.1.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
13.7.1.2. U.S
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging Size
13.7.1.2.1. 1
gm
13.7.1.2.2. 15
gm
13.7.1.2.3. 22
gm
13.7.1.2.4. Others
13.7.1.3. U.S
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
13.7.1.3.1. Paediatric
13.7.1.3.2. Adult
and Elderly
13.7.1.4. U.S
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.7.1.4.1. Online
13.7.1.4.2. Offline
13.7.1.5. U.S Mupirocin
Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
13.7.1.5.1. Hospitals
13.7.1.5.2. Clinics
13.7.1.5.3. Home
Care
13.7.1.5.4. Others
13.7.2. Canada
13.7.2.1. Canada
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
13.7.2.1.1. Impetigo
(School Sores)
13.7.2.1.2. Folliculitis
13.7.2.1.3. Furunculosis
(Boils)
13.7.2.1.4. Ecthyma
13.7.2.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
13.7.2.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
13.7.2.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
13.7.2.2. Canada
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging Size
13.7.2.2.1. 1
gm
13.7.2.2.2. 15
gm
13.7.2.2.3. 22
gm
13.7.2.2.4. Others
13.7.2.3. Canada
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
13.7.2.3.1. Paediatric
13.7.2.3.2. Adult
and Elderly
13.7.2.4. Canada
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.7.2.4.1. Online
13.7.2.4.2. Offline
13.7.2.5. Canada
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
13.7.2.5.1. Hospitals
13.7.2.5.2. Clinics
13.7.2.5.3. Home
Care
13.7.2.5.4. Others
13.7.3. Mexico
13.7.3.1. Mexico
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
13.7.3.1.1. Impetigo
(School Sores)
13.7.3.1.2. Folliculitis
13.7.3.1.3. Furunculosis
(Boils)
13.7.3.1.4. Ecthyma
13.7.3.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
13.7.3.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
13.7.3.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
13.7.3.2. Mexico
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging Size
13.7.3.2.1. 1
gm
13.7.3.2.2. 15
gm
13.7.3.2.3. 22
gm
13.7.3.2.4. Others
13.7.3.3. Mexico
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
13.7.3.3.1. Paediatric
13.7.3.3.2. Adult
and Elderly
13.7.3.4. Mexico
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.7.3.4.1. Online
13.7.3.4.2. Offline
13.7.3.5. Mexico
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
13.7.3.5.1. Hospitals
13.7.3.5.2. Clinics
13.7.3.5.3. Home
Care
13.7.3.5.4. Others
13.7.4. Rest of
North America
13.7.4.1. Rest
of North America Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Application
13.7.4.1.1. Impetigo
(School Sores)
13.7.4.1.2. Folliculitis
13.7.4.1.3. Furunculosis
(Boils)
13.7.4.1.4. Ecthyma
13.7.4.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
13.7.4.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
13.7.4.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
13.7.4.2. Rest
of North America Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Packaging Size
13.7.4.2.1. 1
gm
13.7.4.2.2. 15
gm
13.7.4.2.3. 22
gm
13.7.4.2.4. Others
13.7.4.3. Rest
of North America Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Age Group
13.7.4.3.1. Paediatric
13.7.4.3.2. Adult
and Elderly
13.7.4.4. Rest
of North America Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
13.7.4.4.1. Online
13.7.4.4.2. Offline
13.7.4.5. Rest
of North America Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
End Use
13.7.4.5.1. Hospitals
13.7.4.5.2. Clinics
13.7.4.5.3. Home
Care
13.7.4.5.4. Others
13.8. Key
Segment for Channeling Investments
13.8.1. By
Country
13.8.2. By
Application
13.8.3. By
Packaging Size
13.8.4. By Age
Group
13.8.5. By
Distribution Channel
13.8.6. By End
Use
14.
Europe Mupirocin Ointment
Market Analysis and Forecasts, 2022 – 2030
14.1. Overview
14.1.1. Europe
Mupirocin Ointment Market Revenue (US$ Mn)
14.2. Europe
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
14.2.1. Impetigo
(School Sores)
14.2.2. Folliculitis
14.2.3. Furunculosis
(Boils)
14.2.4. Ecthyma
14.2.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and Ichthyosis)
14.2.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
14.2.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
14.3. Europe
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging Size
14.3.1. 1 gm
14.3.2. 15 gm
14.3.3. 22 gm
14.3.4. Others
14.4. Europe
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
14.4.1. Paediatric
14.4.2. Adult
and Elderly
14.5. Europe
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.5.1. Online
14.5.2. Offline
14.6. Europe
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
14.6.1. Hospitals
14.6.2. Clinics
14.6.3. Home
Care
14.6.4. Others
14.7. Europe
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Country
14.7.1. France
14.7.1.1. France
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
14.7.1.1.1. Impetigo
(School Sores)
14.7.1.1.2. Folliculitis
14.7.1.1.3. Furunculosis
(Boils)
14.7.1.1.4. Ecthyma
14.7.1.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
14.7.1.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
14.7.1.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
14.7.1.2. France
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging Size
14.7.1.2.1. 1
gm
14.7.1.2.2. 15
gm
14.7.1.2.3. 22
gm
14.7.1.2.4. Others
14.7.1.3. France
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
14.7.1.3.1. Paediatric
14.7.1.3.2. Adult
and Elderly
14.7.1.4. France
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.7.1.4.1. Online
14.7.1.4.2. Offline
14.7.1.5. France
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
14.7.1.5.1. Hospitals
14.7.1.5.2. Clinics
14.7.1.5.3. Home
Care
14.7.1.5.4. Others
14.7.2. The UK
14.7.2.1. The
UK Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
14.7.2.1.1. Impetigo
(School Sores)
14.7.2.1.2. Folliculitis
14.7.2.1.3. Furunculosis
(Boils)
14.7.2.1.4. Ecthyma
14.7.2.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
14.7.2.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
14.7.2.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
14.7.2.2. The
UK Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging Size
14.7.2.2.1. 1
gm
14.7.2.2.2. 15
gm
14.7.2.2.3. 22
gm
14.7.2.2.4. Others
14.7.2.3. The
UK Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
14.7.2.3.1. Paediatric
14.7.2.3.2. Adult
and Elderly
14.7.2.4. The
UK Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.7.2.4.1. Online
14.7.2.4.2. Offline
14.7.2.5. The
UK Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
14.7.2.5.1. Hospitals
14.7.2.5.2. Clinics
14.7.2.5.3. Home
Care
14.7.2.5.4. Others
14.7.3. Spain
14.7.3.1. Spain
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
14.7.3.1.1. Impetigo
(School Sores)
14.7.3.1.2. Folliculitis
14.7.3.1.3. Furunculosis
(Boils)
14.7.3.1.4. Ecthyma
14.7.3.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
14.7.3.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
14.7.3.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
14.7.3.2. Spain
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging Size
14.7.3.2.1. 1
gm
14.7.3.2.2. 15
gm
14.7.3.2.3. 22
gm
14.7.3.2.4. Others
14.7.3.3. Spain
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
14.7.3.3.1. Paediatric
14.7.3.3.2. Adult
and Elderly
14.7.3.4. Spain
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.7.3.4.1. Online
14.7.3.4.2. Offline
14.7.3.5. Spain
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
14.7.3.5.1. Hospitals
14.7.3.5.2. Clinics
14.7.3.5.3. Home
Care
14.7.3.5.4. Others
14.7.4. Germany
14.7.4.1. Germany
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
14.7.4.1.1. Impetigo
(School Sores)
14.7.4.1.2. Folliculitis
14.7.4.1.3. Furunculosis
(Boils)
14.7.4.1.4. Ecthyma
14.7.4.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
14.7.4.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
14.7.4.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
14.7.4.2. Germany
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging Size
14.7.4.2.1. 1
gm
14.7.4.2.2. 15
gm
14.7.4.2.3. 22
gm
14.7.4.2.4. Others
14.7.4.3. Germany
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
14.7.4.3.1. Paediatric
14.7.4.3.2. Adult
and Elderly
14.7.4.4. Germany
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.7.4.4.1. Online
14.7.4.4.2. Offline
14.7.4.5. Germany
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
14.7.4.5.1. Hospitals
14.7.4.5.2. Clinics
14.7.4.5.3. Home
Care
14.7.4.5.4. Others
14.7.5. Italy
14.7.5.1. Italy
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
14.7.5.1.1. Impetigo
(School Sores)
14.7.5.1.2. Folliculitis
14.7.5.1.3. Furunculosis
(Boils)
14.7.5.1.4. Ecthyma
14.7.5.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
14.7.5.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
14.7.5.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
14.7.5.2. Italy
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging Size
14.7.5.2.1. 1
gm
14.7.5.2.2. 15
gm
14.7.5.2.3. 22
gm
14.7.5.2.4. Others
14.7.5.3. Italy
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
14.7.5.3.1. Paediatric
14.7.5.3.2. Adult
and Elderly
14.7.5.4. Italy
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.7.5.4.1. Online
14.7.5.4.2. Offline
14.7.5.5. Italy
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
14.7.5.5.1. Hospitals
14.7.5.5.2. Clinics
14.7.5.5.3. Home
Care
14.7.5.5.4. Others
14.7.6. Nordic
Countries
14.7.6.1. Nordic
Countries Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Application
14.7.6.1.1. Impetigo
(School Sores)
14.7.6.1.2. Folliculitis
14.7.6.1.3. Furunculosis
(Boils)
14.7.6.1.4. Ecthyma
14.7.6.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
14.7.6.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
14.7.6.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
14.7.6.2. Nordic
Countries Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Packaging Size
14.7.6.2.1. 1
gm
14.7.6.2.2. 15
gm
14.7.6.2.3. 22
gm
14.7.6.2.4. Others
14.7.6.3. Nordic
Countries Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age
Group
14.7.6.3.1. Paediatric
14.7.6.3.2. Adult
and Elderly
14.7.6.4. Nordic
Countries Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.7.6.4.1. Online
14.7.6.4.2. Offline
14.7.6.5. Nordic
Countries Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
14.7.6.5.1. Hospitals
14.7.6.5.2. Clinics
14.7.6.5.3. Home
Care
14.7.6.5.4. Others
14.7.6.6. Nordic
Countries Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Country
14.7.6.6.1. Denmark
14.7.6.6.2. Finland
14.7.6.6.3. Iceland
14.7.6.6.4. Sweden
14.7.6.6.5. Norway
14.7.7. Benelux
Union
14.7.7.1. Benelux
Union Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
14.7.7.1.1. Impetigo
(School Sores)
14.7.7.1.2. Folliculitis
14.7.7.1.3. Furunculosis
(Boils)
14.7.7.1.4. Ecthyma
14.7.7.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
14.7.7.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
14.7.7.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
14.7.7.2. Benelux
Union Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging
Size
14.7.7.2.1. 1
gm
14.7.7.2.2. 15
gm
14.7.7.2.3. 22
gm
14.7.7.2.4. Others
14.7.7.3. Benelux
Union Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
14.7.7.3.1. Paediatric
14.7.7.3.2. Adult
and Elderly
14.7.7.4. Benelux
Union Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.7.7.4.1. Online
14.7.7.4.2. Offline
14.7.7.5. Benelux
Union Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
14.7.7.5.1. Hospitals
14.7.7.5.2. Clinics
14.7.7.5.3. Home
Care
14.7.7.5.4. Others
14.7.7.6. Benelux
Union Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Country
14.7.7.6.1. Belgium
14.7.7.6.2. The
Netherlands
14.7.7.6.3. Luxembourg
14.7.8. Rest of
Europe
14.7.8.1. Rest
of Europe Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Application
14.7.8.1.1. Impetigo
(School Sores)
14.7.8.1.2. Folliculitis
14.7.8.1.3. Furunculosis
(Boils)
14.7.8.1.4. Ecthyma
14.7.8.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
14.7.8.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
14.7.8.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
14.7.8.2. Rest
of Europe Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Packaging Size
14.7.8.2.1. 1
gm
14.7.8.2.2. 15
gm
14.7.8.2.3. 22
gm
14.7.8.2.4. Others
14.7.8.3. Rest
of Europe Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age
Group
14.7.8.3.1. Paediatric
14.7.8.3.2. Adult
and Elderly
14.7.8.4. Rest
of Europe Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.7.8.4.1. Online
14.7.8.4.2. Offline
14.7.8.5. Rest
of Europe Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
14.7.8.5.1. Hospitals
14.7.8.5.2. Clinics
14.7.8.5.3. Home
Care
14.7.8.5.4. Others
14.8. Key
Segment for Channeling Investments
14.8.1. By
Country
14.8.2. By
Application
14.8.3. By Packaging
Size
14.8.4. By Age
Group
14.8.5. By
Distribution Channel
14.8.6. By End
Use
15.
Asia Pacific Mupirocin
Ointment Market Analysis and Forecasts, 2022 – 2030
15.1. Overview
15.1.1. Asia
Pacific Mupirocin Ointment Market Revenue (US$ Mn)
15.2. Asia
Pacific Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Application
15.2.1. Impetigo
(School Sores)
15.2.2. Folliculitis
15.2.3. Furunculosis
(Boils)
15.2.4. Ecthyma
15.2.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
15.2.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
15.2.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
15.3. Asia
Pacific Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging
Size
15.3.1. 1 gm
15.3.2. 15 gm
15.3.3. 22 gm
15.3.4. Others
15.4. Asia Pacific
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
15.4.1. Paediatric
15.4.2. Adult
and Elderly
15.5. Asia
Pacific Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.5.1. Online
15.5.2. Offline
15.6. Asia
Pacific Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
15.6.1. Hospitals
15.6.2. Clinics
15.6.3. Home
Care
15.6.4. Others
15.7. Asia
Pacific Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Country
15.7.1. China
15.7.1.1. China
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
15.7.1.1.1. Impetigo
(School Sores)
15.7.1.1.2. Folliculitis
15.7.1.1.3. Furunculosis
(Boils)
15.7.1.1.4. Ecthyma
15.7.1.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
15.7.1.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
15.7.1.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
15.7.1.2. China
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging Size
15.7.1.2.1. 1
gm
15.7.1.2.2. 15
gm
15.7.1.2.3. 22
gm
15.7.1.2.4. Others
15.7.1.3. China
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
15.7.1.3.1. Paediatric
15.7.1.3.2. Adult
and Elderly
15.7.1.4. China
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.7.1.4.1. Online
15.7.1.4.2. Offline
15.7.1.5. China
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
15.7.1.5.1. Hospitals
15.7.1.5.2. Clinics
15.7.1.5.3. Home
Care
15.7.1.5.4. Others
15.7.2. Japan
15.7.2.1. Japan
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
15.7.2.1.1. Impetigo
(School Sores)
15.7.2.1.2. Folliculitis
15.7.2.1.3. Furunculosis
(Boils)
15.7.2.1.4. Ecthyma
15.7.2.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
15.7.2.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
15.7.2.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
15.7.2.2. Japan
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging Size
15.7.2.2.1. 1
gm
15.7.2.2.2. 15
gm
15.7.2.2.3. 22
gm
15.7.2.2.4. Others
15.7.2.3. Japan
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
15.7.2.3.1. Paediatric
15.7.2.3.2. Adult
and Elderly
15.7.2.4. Japan
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.7.2.4.1. Online
15.7.2.4.2. Offline
15.7.2.5. Japan
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
15.7.2.5.1. Hospitals
15.7.2.5.2. Clinics
15.7.2.5.3. Home
Care
15.7.2.5.4. Others
15.7.3. India
15.7.3.1. India
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
15.7.3.1.1. Impetigo
(School Sores)
15.7.3.1.2. Folliculitis
15.7.3.1.3. Furunculosis
(Boils)
15.7.3.1.4. Ecthyma
15.7.3.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
15.7.3.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
15.7.3.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
15.7.3.2. India
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging Size
15.7.3.2.1. 1
gm
15.7.3.2.2. 15
gm
15.7.3.2.3. 22
gm
15.7.3.2.4. Others
15.7.3.3. India
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
15.7.3.3.1. Paediatric
15.7.3.3.2. Adult
and Elderly
15.7.3.4. India
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.7.3.4.1. Online
15.7.3.4.2. Offline
15.7.3.5. India
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
15.7.3.5.1. Hospitals
15.7.3.5.2. Clinics
15.7.3.5.3. Home
Care
15.7.3.5.4. Others
15.7.4. New
Zealand
15.7.4.1. New
Zealand Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Application
15.7.4.1.1. Impetigo
(School Sores)
15.7.4.1.2. Folliculitis
15.7.4.1.3. Furunculosis
(Boils)
15.7.4.1.4. Ecthyma
15.7.4.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
15.7.4.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
15.7.4.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
15.7.4.2. New
Zealand Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging
Size
15.7.4.2.1. 1
gm
15.7.4.2.2. 15
gm
15.7.4.2.3. 22
gm
15.7.4.2.4. Others
15.7.4.3. New
Zealand Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
15.7.4.3.1. Paediatric
15.7.4.3.2. Adult
and Elderly
15.7.4.4. New
Zealand Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.7.4.4.1. Online
15.7.4.4.2. Offline
15.7.4.5. New
Zealand Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
15.7.4.5.1. Hospitals
15.7.4.5.2. Clinics
15.7.4.5.3. Home
Care
15.7.4.5.4. Others
15.7.5. Australia
15.7.5.1. Australia
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
15.7.5.1.1. Impetigo
(School Sores)
15.7.5.1.2. Folliculitis
15.7.5.1.3. Furunculosis
(Boils)
15.7.5.1.4. Ecthyma
15.7.5.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
15.7.5.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
15.7.5.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
15.7.5.2. Australia
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging Size
15.7.5.2.1. 1
gm
15.7.5.2.2. 15
gm
15.7.5.2.3. 22
gm
15.7.5.2.4. Others
15.7.5.3. Australia
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
15.7.5.3.1. Paediatric
15.7.5.3.2. Adult
and Elderly
15.7.5.4. Australia
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.7.5.4.1. Online
15.7.5.4.2. Offline
15.7.5.5. Australia
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
15.7.5.5.1. Hospitals
15.7.5.5.2. Clinics
15.7.5.5.3. Home
Care
15.7.5.5.4. Others
15.7.6. South
Korea
15.7.6.1. South
Korea Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
15.7.6.1.1. Impetigo
(School Sores)
15.7.6.1.2. Folliculitis
15.7.6.1.3. Furunculosis
(Boils)
15.7.6.1.4. Ecthyma
15.7.6.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
15.7.6.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
15.7.6.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
15.7.6.2. South
Korea Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging
Size
15.7.6.2.1. 1
gm
15.7.6.2.2. 15
gm
15.7.6.2.3. 22
gm
15.7.6.2.4. Others
15.7.6.3. South
Korea Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
15.7.6.3.1. Paediatric
15.7.6.3.2. Adult
and Elderly
15.7.6.4. South
Korea Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.7.6.4.1. Online
15.7.6.4.2. Offline
15.7.6.5. South
Korea Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
15.7.6.5.1. Hospitals
15.7.6.5.2. Clinics
15.7.6.5.3. Home
Care
15.7.6.5.4. Others
15.7.7. Southeast
Asia
15.7.7.1. Southeast
Asia Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
15.7.7.1.1. Impetigo
(School Sores)
15.7.7.1.2. Folliculitis
15.7.7.1.3. Furunculosis
(Boils)
15.7.7.1.4. Ecthyma
15.7.7.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
15.7.7.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
15.7.7.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
15.7.7.2. Southeast
Asia Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging
Size
15.7.7.2.1. 1
gm
15.7.7.2.2. 15
gm
15.7.7.2.3. 22
gm
15.7.7.2.4. Others
15.7.7.3. Southeast
Asia Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
15.7.7.3.1. Paediatric
15.7.7.3.2. Adult
and Elderly
15.7.7.4. Southeast
Asia Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.7.7.4.1. Online
15.7.7.4.2. Offline
15.7.7.5. Southeast
Asia Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
15.7.7.5.1. Hospitals
15.7.7.5.2. Clinics
15.7.7.5.3. Home
Care
15.7.7.5.4. Others
15.7.7.6. Southeast
Asia Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Country
15.7.7.6.1. Indonesia
15.7.7.6.2. Thailand
15.7.7.6.3. Malaysia
15.7.7.6.4. Singapore
15.7.7.6.5. Rest
of Southeast Asia
15.7.8. Rest of
Asia Pacific
15.7.8.1. Rest
of Asia Pacific Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Application
15.7.8.1.1. Impetigo
(School Sores)
15.7.8.1.2. Folliculitis
15.7.8.1.3. Furunculosis
(Boils)
15.7.8.1.4. Ecthyma
15.7.8.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
15.7.8.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
15.7.8.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
15.7.8.2. Rest
of Asia Pacific Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Packaging Size
15.7.8.2.1. 1
gm
15.7.8.2.2. 15
gm
15.7.8.2.3. 22
gm
15.7.8.2.4. Others
15.7.8.3. Rest
of Asia Pacific Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Age Group
15.7.8.3.1. Paediatric
15.7.8.3.2. Adult
and Elderly
15.7.8.4. Rest
of Asia Pacific Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.7.8.4.1. Online
15.7.8.4.2. Offline
15.7.8.5. Rest
of Asia Pacific Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
End Use
15.7.8.5.1. Hospitals
15.7.8.5.2. Clinics
15.7.8.5.3. Home
Care
15.7.8.5.4. Others
15.8. Key
Segment for Channeling Investments
15.8.1. By
Country
15.8.2. By
Application
15.8.3. By
Packaging Size
15.8.4. By Age
Group
15.8.5. By
Distribution Channel
15.8.6. By End
Use
16.
Middle East and Africa
Mupirocin Ointment Market Analysis and Forecasts, 2022 – 2030
16.1. Overview
16.1.1. Middle
East and Africa Mupirocin Ointment Market Revenue (US$ Mn)
16.2. Middle
East and Africa Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Application
16.2.1. Impetigo
(School Sores)
16.2.2. Folliculitis
16.2.3. Furunculosis
(Boils)
16.2.4. Ecthyma
16.2.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
16.2.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
16.2.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
16.3. Middle
East and Africa Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Packaging Size
16.3.1. 1 gm
16.3.2. 15 gm
16.3.3. 22 gm
16.3.4. Others
16.4. Middle
East and Africa Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Age Group
16.4.1. Paediatric
16.4.2. Adult
and Elderly
16.5. Middle
East and Africa Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.5.1. Online
16.5.2. Offline
16.6. Middle
East and Africa Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
End Use
16.6.1. Hospitals
16.6.2. Clinics
16.6.3. Home
Care
16.6.4. Others
16.7. Middle
East and Africa Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Country
16.7.1. Saudi
Arabia
16.7.1.1. Saudi
Arabia Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
16.7.1.1.1. Impetigo
(School Sores)
16.7.1.1.2. Folliculitis
16.7.1.1.3. Furunculosis
(Boils)
16.7.1.1.4. Ecthyma
16.7.1.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
16.7.1.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
16.7.1.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
16.7.1.2. Saudi
Arabia Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging
Size
16.7.1.2.1. 1
gm
16.7.1.2.2. 15
gm
16.7.1.2.3. 22
gm
16.7.1.2.4. Others
16.7.1.3. Saudi
Arabia Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
16.7.1.3.1. Paediatric
16.7.1.3.2. Adult
and Elderly
16.7.1.4. Saudi
Arabia Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.7.1.4.1. Online
16.7.1.4.2. Offline
16.7.1.5. Saudi
Arabia Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
16.7.1.5.1. Hospitals
16.7.1.5.2. Clinics
16.7.1.5.3. Home
Care
16.7.1.5.4. Others
16.7.2. UAE
16.7.2.1. UAE
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
16.7.2.1.1. Impetigo
(School Sores)
16.7.2.1.2. Folliculitis
16.7.2.1.3. Furunculosis
(Boils)
16.7.2.1.4. Ecthyma
16.7.2.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
16.7.2.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
16.7.2.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
16.7.2.2. UAE
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging Size
16.7.2.2.1. 1
gm
16.7.2.2.2. 15
gm
16.7.2.2.3. 22
gm
16.7.2.2.4. Others
16.7.2.3. UAE
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
16.7.2.3.1. Paediatric
16.7.2.3.2. Adult
and Elderly
16.7.2.4. UAE
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
16.7.2.4.1. Online
16.7.2.4.2. Offline
16.7.2.5. UAE
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
16.7.2.5.1. Hospitals
16.7.2.5.2. Clinics
16.7.2.5.3. Home
Care
16.7.2.5.4. Others
16.7.3. Egypt
16.7.3.1. Egypt
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
16.7.3.1.1. Impetigo
(School Sores)
16.7.3.1.2. Folliculitis
16.7.3.1.3. Furunculosis
(Boils)
16.7.3.1.4. Ecthyma
16.7.3.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
16.7.3.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
16.7.3.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
16.7.3.2. Egypt
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging Size
16.7.3.2.1. 1
gm
16.7.3.2.2. 15
gm
16.7.3.2.3. 22
gm
16.7.3.2.4. Others
16.7.3.3. Egypt
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
16.7.3.3.1. Paediatric
16.7.3.3.2. Adult
and Elderly
16.7.3.4. Egypt
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
16.7.3.4.1. Online
16.7.3.4.2. Offline
16.7.3.5. Egypt
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
16.7.3.5.1. Hospitals
16.7.3.5.2. Clinics
16.7.3.5.3. Home
Care
16.7.3.5.4. Others
16.7.4. Kuwait
16.7.4.1. Kuwait
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
16.7.4.1.1. Impetigo
(School Sores)
16.7.4.1.2. Folliculitis
16.7.4.1.3. Furunculosis
(Boils)
16.7.4.1.4. Ecthyma
16.7.4.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
16.7.4.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
16.7.4.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
16.7.4.2. Kuwait
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging Size
16.7.4.2.1. 1
gm
16.7.4.2.2. 15
gm
16.7.4.2.3. 22
gm
16.7.4.2.4. Others
16.7.4.3. Kuwait
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
16.7.4.3.1. Paediatric
16.7.4.3.2. Adult
and Elderly
16.7.4.4. Kuwait
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
16.7.4.4.1. Online
16.7.4.4.2. Offline
16.7.4.5. Kuwait
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
16.7.4.5.1. Hospitals
16.7.4.5.2. Clinics
16.7.4.5.3. Home
Care
16.7.4.5.4. Others
16.7.5. South
Africa
16.7.5.1. South
Africa Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
16.7.5.1.1. Impetigo
(School Sores)
16.7.5.1.2. Folliculitis
16.7.5.1.3. Furunculosis
(Boils)
16.7.5.1.4. Ecthyma
16.7.5.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
16.7.5.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
16.7.5.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
16.7.5.2. South
Africa Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging
Size
16.7.5.2.1. 1
gm
16.7.5.2.2. 15
gm
16.7.5.2.3. 22
gm
16.7.5.2.4. Others
16.7.5.3. South
Africa Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
16.7.5.3.1. Paediatric
16.7.5.3.2. Adult
and Elderly
16.7.5.4. South
Africa Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.7.5.4.1. Online
16.7.5.4.2. Offline
16.7.5.5. South
Africa Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
16.7.5.5.1. Hospitals
16.7.5.5.2. Clinics
16.7.5.5.3. Home
Care
16.7.5.5.4. Others
16.7.6. Rest of
Middle East & Africa
16.7.6.1. Rest
of Middle East & Africa Mupirocin Ointment Market Revenue (US$ Mn) and
Forecasts, By Application
16.7.6.1.1. Impetigo
(School Sores)
16.7.6.1.2. Folliculitis
16.7.6.1.3. Furunculosis
(Boils)
16.7.6.1.4. Ecthyma
16.7.6.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
16.7.6.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
16.7.6.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
16.7.6.2. Rest
of Middle East & Africa Mupirocin Ointment Market Revenue (US$ Mn) and
Forecasts, By Packaging Size
16.7.6.2.1. 1
gm
16.7.6.2.2. 15
gm
16.7.6.2.3. 22
gm
16.7.6.2.4. Others
16.7.6.3. Rest
of Middle East & Africa Mupirocin Ointment Market Revenue (US$ Mn) and
Forecasts, By Age Group
16.7.6.3.1. Paediatric
16.7.6.3.2. Adult
and Elderly
16.7.6.4. Rest
of Middle East & Africa Mupirocin Ointment Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
16.7.6.4.1. Online
16.7.6.4.2. Offline
16.7.6.5. Rest
of Middle East & Africa Mupirocin Ointment Market Revenue (US$ Mn) and
Forecasts, By End Use
16.7.6.5.1. Hospitals
16.7.6.5.2. Clinics
16.7.6.5.3. Home
Care
16.7.6.5.4. Others
16.8. Key
Segment for Channeling Investments
16.8.1. By
Country
16.8.2. By
Application
16.8.3. By
Packaging Size
16.8.4. By Age
Group
16.8.5. By
Distribution Channel
16.8.6. By End
Use
17.
Latin America Mupirocin
Ointment Market Analysis and Forecasts, 2022 – 2030
17.1. Overview
17.1.1. Latin
America Mupirocin Ointment Market Revenue (US$ Mn)
17.2. Latin
America Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Application
17.2.1. Impetigo
(School Sores)
17.2.2. Folliculitis
17.2.3. Furunculosis
(Boils)
17.2.4. Ecthyma
17.2.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
17.2.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
17.2.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
17.3. Latin
America Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging
Size
17.3.1. 1 gm
17.3.2. 15 gm
17.3.3. 22 gm
17.3.4. Others
17.4. Latin
America Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
17.4.1. Paediatric
17.4.2. Adult
and Elderly
17.5. Latin
America Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
17.5.1. Online
17.5.2. Offline
17.6. Latin
America Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
17.6.1. Hospitals
17.6.2. Clinics
17.6.3. Home
Care
17.6.4. Others
17.7. Latin
America Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Country
17.7.1. Brazil
17.7.1.1. Brazil
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
17.7.1.1.1. Impetigo
(School Sores)
17.7.1.1.2. Folliculitis
17.7.1.1.3. Furunculosis
(Boils)
17.7.1.1.4. Ecthyma
17.7.1.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
17.7.1.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
17.7.1.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
17.7.1.2. Brazil
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging Size
17.7.1.2.1. 1
gm
17.7.1.2.2. 15
gm
17.7.1.2.3. 22 gm
17.7.1.2.4. Others
17.7.1.3. Brazil
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
17.7.1.3.1. Paediatric
17.7.1.3.2. Adult
and Elderly
17.7.1.4. Brazil
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
17.7.1.4.1. Online
17.7.1.4.2. Offline
17.7.1.5. Brazil
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
17.7.1.5.1. Hospitals
17.7.1.5.2. Clinics
17.7.1.5.3. Home
Care
17.7.1.5.4. Others
17.7.2. Argentina
17.7.2.1. Argentina
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Application
17.7.2.1.1. Impetigo
(School Sores)
17.7.2.1.2. Folliculitis
17.7.2.1.3. Furunculosis
(Boils)
17.7.2.1.4. Ecthyma
17.7.2.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
17.7.2.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
17.7.2.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
17.7.2.2. Argentina
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Packaging Size
17.7.2.2.1. 1
gm
17.7.2.2.2. 15
gm
17.7.2.2.3. 22
gm
17.7.2.2.4. Others
17.7.2.3. Argentina
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Age Group
17.7.2.3.1. Paediatric
17.7.2.3.2. Adult
and Elderly
17.7.2.4. Argentina
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
17.7.2.4.1. Online
17.7.2.4.2. Offline
17.7.2.5. Argentina
Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By End Use
17.7.2.5.1. Hospitals
17.7.2.5.2. Clinics
17.7.2.5.3. Home
Care
17.7.2.5.4. Others
17.7.3. Rest of
Latin America
17.7.3.1. Rest
of Latin America Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Application
17.7.3.1.1. Impetigo
(School Sores)
17.7.3.1.2. Folliculitis
17.7.3.1.3. Furunculosis
(Boils)
17.7.3.1.4. Ecthyma
17.7.3.1.5. Infected
Dermatoses (Eczema, Psoriasis, Atopic Dermatitis, Epidermolysis Bullosa and
Ichthyosis)
17.7.3.1.6. Infected
Traumatic Lesions (Ulcers, Minor Burns, Abrasions, Cuts and Wounds)
17.7.3.1.7. Prevent
Development of Infection and Promote Healing in Minor Burns, Biopsy Sites,
Minor Cuts and Other Clean Lesions
17.7.3.2. Rest
of Latin America Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Packaging Size
17.7.3.2.1. 1
gm
17.7.3.2.2. 15
gm
17.7.3.2.3. 22
gm
17.7.3.2.4. Others
17.7.3.3. Rest
of Latin America Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Age Group
17.7.3.3.1. Paediatric
17.7.3.3.2. Adult
and Elderly
17.7.3.4. Rest
of Latin America Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
17.7.3.4.1. Online
17.7.3.4.2. Offline
17.7.3.5. Rest
of Latin America Mupirocin Ointment Market Revenue (US$ Mn) and Forecasts, By
End Use
17.7.3.5.1. Hospitals
17.7.3.5.2. Clinics
17.7.3.5.3. Home
Care
17.7.3.5.4. Others
17.8. Key
Segment for Channeling Investments
17.8.1. By
Country
17.8.2. By
Application
17.8.3. By
Packaging Size
17.8.4. By Age
Group
17.8.5. By
Distribution Channel
17.8.6. By End
Use
18.
Competitive Benchmarking
18.1. Brand
Benchmarking
18.2. Market
Share Analysis, 2021
18.3. Global
Presence and Growth Strategies
18.3.1. Mergers
and Acquisitions
18.3.2. Product
Launches
18.3.3. Investments
Trends
18.3.4. R&D
Initiatives
19.
Player Profiles
19.1. Cipla
Limited
19.1.1. Company
Details
19.1.2. Company
Overview
19.1.3. Product
Offerings
19.1.4. Key
Developments
19.1.5. Financial
Analysis
19.1.6. SWOT
Analysis
19.1.7. Business
Strategies
19.2. Glaxosmithkline
19.2.1. Company
Details
19.2.2. Company
Overview
19.2.3. Product
Offerings
19.2.4. Key
Developments
19.2.5. Financial
Analysis
19.2.6. SWOT
Analysis
19.2.7. Business
Strategies
19.3. Glenmark
Pharmaceutical Inc.
19.3.1. Company
Details
19.3.2. Company
Overview
19.3.3. Product
Offerings
19.3.4. Key
Developments
19.3.5. Financial
Analysis
19.3.6. SWOT
Analysis
19.3.7. Business
Strategies
19.4. Perrigo
Company
19.4.1. Company
Details
19.4.2. Company
Overview
19.4.3. Product
Offerings
19.4.4. Key
Developments
19.4.5. Financial
Analysis
19.4.6. SWOT
Analysis
19.4.7. Business
Strategies
19.5. Sandoz AG
19.5.1. Company
Details
19.5.2. Company
Overview
19.5.3. Product
Offerings
19.5.4. Key
Developments
19.5.5. Financial
Analysis
19.5.6. SWOT
Analysis
19.5.7. Business
Strategies
19.6. Sun
Pharma
19.6.1. Company
Details
19.6.2. Company
Overview
19.6.3. Product
Offerings
19.6.4. Key
Developments
19.6.5. Financial
Analysis
19.6.6. SWOT
Analysis
19.6.7. Business
Strategies
19.7. Teva
Pharmaceuticals USA, Inc
19.7.1. Company
Details
19.7.2. Company
Overview
19.7.3. Product
Offerings
19.7.4. Key
Developments
19.7.5. Financial
Analysis
19.7.6. SWOT
Analysis
19.7.7. Business
Strategies
19.8. Texas
Pharmaceuticals
19.8.1. Company
Details
19.8.2. Company
Overview
19.8.3. Product
Offerings
19.8.4. Key
Developments
19.8.5. Financial
Analysis
19.8.6. SWOT
Analysis
19.8.7. Business
Strategies
19.9. Unichem
Laboratories
19.9.1. Company
Details
19.9.2. Company
Overview
19.9.3. Product
Offerings
19.9.4. Key
Developments
19.9.5. Financial
Analysis
19.9.6. SWOT
Analysis
19.9.7. Business
Strategies
19.10. Other
Market Participants
20. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.